Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
New to The Street Signs Acurx Pharmaceuticals, Inc. to Additional Six-Month Media Contract with Iconic Billboard Ads and Commercial Support
March 23, 2023 16:00 ET
|
FMW Media Works Corp
NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- FMW Media's business TV show, New to The Street, announces signing Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP) ("Acurx") to an additional...
Alvotech to Present Clinical Study Data for AVT04, a Proposed Biosimilar to Stelara®, at 2023 American Academy of Dermatology (AAD) Annual Meeting
March 17, 2023 09:10 ET
|
Alvotech
Alvotech to present two posters related to pharmacokinetics and confirmatory clinical studies for AVT04 (ustekinumab), a proposed biosimilar to Stelara® Marketing applications for AVT04 have been...
Alvotech kynnir niðurstöður klínískra rannsókna á AVT04, fyrirhugaðri hliðstæðu við Stelara á ársþingi samtaka bandarískra húðsjúkdómalækna (AAD)
March 17, 2023 09:10 ET
|
Alvotech
Alvotech kynnir niðurstöður úr rannsókn á lyfjahvörfum og klínískri rannsókn á sjúklingum fyrir AVT04 (ustekinumab), fyrirhugaða líftæknilyfjahliðstæðu við StelaraUmsóknir um markaðsleyfi fyrir AVT04...
Alvotech to Present Clinical Study Data for AVT04, a Proposed Biosimilar to Stelara®, at 2023 American Academy of Dermatology (AAD) Annual Meeting
March 17, 2023 09:10 ET
|
Alvotech
Alvotech to present two posters related to pharmacokinetics and confirmatory clinical studies for AVT04 (ustekinumab), a proposed biosimilar to Stelara®Marketing applications for AVT04 have been...
Updated market making agreement with Landsbankinn for Alvotech shares trading on the Nasdaq Iceland market
February 14, 2023 16:01 ET
|
Alvotech
Alvotech (Nasdaq: ALVO) and Landsbankinn hf. have updated their market making agreement, which has been in effect since Alvotech’s shares were admitted to trading in Iceland on June 23, 2022. The...
Uppfærður samningur við Landsbankann um viðskiptavakt á hlutabréfum Alvotech á Nasdaq Iceland markaðnum
February 14, 2023 16:01 ET
|
Alvotech
Alvotech (NASDAQ: ALVO) tilkynnti í dag að samningur við Landsbankann hf. um viðskiptavakt á hlutabréfum Alvotech hafi verið uppfærður, en Landsbankinn hefur séð um viðskiptavakt á hlutabréfunum síðan...
Settlement of Alvotech Private Share Placement Completed
February 10, 2023 16:01 ET
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today the completion of the equity...
Uppgjöri viðskipta í lokuðu hlutafjárútboði lokið
February 10, 2023 16:01 ET
|
Alvotech
Alvotech (NASDAQ: ALVO) tilkynnti í dag að uppgjöri viðskipta í lokuðu hlutafjárútboði sem tilkynnt var um 23. janúar sl. væri nú lokið. Alls hafa 11.834.061 hlutabréf í Alvotech sem áður voru í eigu...
EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
February 09, 2023 02:30 ET
|
Alvotech
Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) EMA opinion on AVT04 could come as soon as the...
Evrópska lyfjastofnunin samþykkir að taka fyrir leyfisumsókn fyrir fyrirhugaða hliðstæðu við Stelara® (ustekinumab)
February 09, 2023 02:30 ET
|
Alvotech
Álit Evrópsku lyfjastofnunarinnar (EMA) gæti legið fyrir á síðari helmingi ársins 2023Frumlyfið Stelara® (ustekinumab) er gefið sjúklingum með ýmsa bólgusjúkdóma Alvotech (NASDAQ: ALVO) og alþjóðlega...